e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

265.70 -0.02 (-0.01%)

Delayed Quote Updated: 1:25 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

39 40 Next >

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading

March 13, 2023

Via Investor Brand Network

Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail ↗

March 13, 2023

Icahn is reportedly planning a proxy fight with Illumina, frustrated by the Grail efforts.

Via Investor's Business Daily

Why Illumina Shares Are Soaring Today? ↗

March 13, 2023

Via Benzinga

A Look Into Illumina's Debt ↗

March 06, 2023

Via Benzinga

How Is The Market Feeling About Illumina? ↗

March 06, 2023

Via Benzinga

DNA-Reading Giant Illumina Topples On Wide Profit Miss ↗

February 07, 2023

Sales narrowly topped expectations, however.

Via Investor's Business Daily

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Is ROKU Stock Down Today? ↗

March 13, 2023

Roku (ROKU) stock is taking a beating on Monday after it was revealed a large portion of the company's funds were held at Silicon Valley Bank.

Via InvestorPlace

ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina ↗

March 13, 2023

Illumina (ILMN) stock is a hot topic among traders on Monday as reports claim Carl Icahn is gearing up for a proxy fight.

Via InvestorPlace

Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows ↗

March 13, 2023

After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.

Via Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today ↗

February 07, 2023

Via Benzinga

Earnings Preview For Illumina ↗

February 06, 2023

Via Benzinga

7 Analysts Have This to Say About Illumina ↗

January 25, 2023

Via Benzinga

Church & Dwight, A. O. Smith, Illumina And This US Bank Are CNBC's 'Final Trades' ↗

March 10, 2023

On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said Church & Dwight Co., Inc. (NYSE: CHD) has consolidated the recent gains and is likely

Via Benzinga

DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina

March 07, 2023

Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

March 02, 2023

Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry

From Myriad Genetics, Inc.

Via GlobeNewswire

The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks ↗

February 24, 2023

Startling cancer vaccine results from Moderna may point to the next big thing in biotech.

Via Investor's Business Daily

Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023

February 16, 2023

Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),...

Via SBWire

Topics Economy

Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029

February 14, 2023

Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,...

Via SBWire

7 Stocks to Buy and Hold for the Next 20 Years ↗

February 12, 2023

When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors.

Via InvestorPlace

Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here' ↗

February 08, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending."

Via Benzinga

New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges

February 07, 2023

InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP.

Via Newswire.com

US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy ↗

February 07, 2023

Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading:

Via Benzinga

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗

February 06, 2023

Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023 ↗

January 25, 2023

Via Benzinga

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

Illumina Shares Tank After Annual Guidance Fall Short Of Expectations ↗

January 10, 2023

Via Benzinga

Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech

January 10, 2023

CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key...

Via PRLog

Topics Intellectual Property

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy